138 related articles for article (PubMed ID: 6613837)
1. Ocular effects in long-term amiodarone therapy.
Ingram DV
Am Heart J; 1983 Oct; 106(4 Pt 2):902-5. PubMed ID: 6613837
[TBL] [Abstract][Full Text] [Related]
2. Ocular changes resulting from therapy with amiodarone.
Ingram DV; Jaggarao NS; Chamberlain DA
Br J Ophthalmol; 1982 Oct; 66(10):676-9. PubMed ID: 7115651
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone keratopathy.
Klingele TG; Alves LE; Rose EP
Ann Ophthalmol; 1984 Dec; 16(12):1172-6. PubMed ID: 6532293
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone-induced ultrastructural changes in human eyes.
Ghosh M; McCulloch C
Can J Ophthalmol; 1984 Jun; 19(4):178-86. PubMed ID: 6744103
[TBL] [Abstract][Full Text] [Related]
5. Side effects and possible contraindications of amiodarone use.
Harris L; McKenna WJ; Rowland E; Krikler DM
Am Heart J; 1983 Oct; 106(4 Pt 2):916-23. PubMed ID: 6613838
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone-induced cutaneous and corneal pigment deposits.
Onofrey BE; Jones WL; Magnus DE
J Am Optom Assoc; 1984 May; 55(5):337-9. PubMed ID: 6725829
[No Abstract] [Full Text] [Related]
7. Drug induced ocular lipoidosis.
Clemett RS; MacKintosh HT
Trans Ophthalmol Soc N Z; 1982; 34():52-8. PubMed ID: 6979822
[No Abstract] [Full Text] [Related]
8. Amiodarone-induced corneal deposits.
Kaplan LJ; Cappaert WE
Ann Ophthalmol; 1984 Aug; 16(8):762-66. PubMed ID: 6497223
[TBL] [Abstract][Full Text] [Related]
9. Ocular toxicity of systemic medications: a case series.
To TQ; Townsend JC
Optometry; 2000 Jan; 71(1):29-39. PubMed ID: 10680416
[TBL] [Abstract][Full Text] [Related]
10. Side effects and complications of amiodarone therapy.
Raeder EA; Podrid PJ; Lown B
Am Heart J; 1985 May; 109(5 Pt 1):975-83. PubMed ID: 3158188
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience and grading of amiodarone keratopathy.
Orlando RG; Dangel ME; Schaal SF
Ophthalmology; 1984 Oct; 91(10):1184-7. PubMed ID: 6514284
[TBL] [Abstract][Full Text] [Related]
12. [Complications of long-term treatment with amiodarone].
Aleksandrow D; Aleksandrow W; Dyduszyński A; Wegrzyn B
Kardiol Pol; 1984; 27(1):77-83. PubMed ID: 6716761
[No Abstract] [Full Text] [Related]
13. Ocular Adverse Effects of Amiodarone: A Systematic Review of Case Reports.
Alshehri M; Joury A
Optom Vis Sci; 2020 Jul; 97(7):536-542. PubMed ID: 32697562
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone keratopathy.
Feiler-Ofry V; Lazar M; Solomon A; Godel V
Ophthalmologica; 1980; 180(5):257-61. PubMed ID: 7207963
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone keratopathy. Correlation to dosage and duration.
Kaplan LJ; Cappaert WE
Arch Ophthalmol; 1982 Apr; 100(4):601-2. PubMed ID: 7073573
[TBL] [Abstract][Full Text] [Related]
16. [The keratopathy caused by cordarone (amiodarone). Unusual aspects].
Miglior M
Arch Maragliano Patol Clin; 1974; 30(2):231-6. PubMed ID: 4480709
[No Abstract] [Full Text] [Related]
17. Amiodarone keratopathy: drug-induced lipid storage disease.
D'Amico DJ; Kenyon KR; Ruskin JN
Arch Ophthalmol; 1981 Feb; 99(2):257-61. PubMed ID: 6258544
[TBL] [Abstract][Full Text] [Related]
18. [Amiodarone-induced keratopathy].
Reĭngardiene DI; Azaravichiene AP; Vashkeliene II
Kardiologiia; 2003; 43(5):56-9. PubMed ID: 12891242
[TBL] [Abstract][Full Text] [Related]
19. [Side-effects of amiodarone therapy].
Marchi F
Arch Maragliano Patol Clin; 1974; 30(2):237-43. PubMed ID: 4480710
[No Abstract] [Full Text] [Related]
20. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Stäubli M; Bircher J; Galeazzi RL; Remund H; Studer H
Eur J Clin Pharmacol; 1983; 24(4):485-94. PubMed ID: 6861863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
